Acadian Asset Management’s ADC Therapeutics ADCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-16,454
| Closed | -$51K | – | 2052 |
|
|
2024
Q2 | $51K | Buy |
+16,454
| New | +$51K | ﹤0.01% | 1603 |
|
|
2024
Q1 | – | Sell |
-144,858
| Closed | -$240K | – | 1546 |
|
|
2023
Q4 | $240K | Sell |
144,858
-11,190
| -7% | -$18.5K | ﹤0.01% | 1201 |
|
|
2023
Q3 | $138K | Buy |
156,048
+134,186
| +614% | +$119K | ﹤0.01% | 1256 |
|
|
2023
Q2 | $45K | Buy |
+21,862
| New | +$45K | ﹤0.01% | 1545 |
|
|
2023
Q1 | – | Sell |
-2,695
| Closed | -$10K | – | 1715 |
|
|
2022
Q4 | $10K | Buy |
+2,695
| New | +$10K | ﹤0.01% | 1736 |
|